By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Transition Therapeutics Inc. 

415 Yonge Street
Suite 1103
Toronto  Ontario  M5B2E7  Canada
Phone: 416-260-7770 Fax: 416-260-2886


SEARCH JOBS








Company News
Transition Therapeutics (TTH.TO) Announces Third Quarter Fiscal 2016 Financial Results 5/12/2016 7:02:42 AM
Transition Therapeutics (TTH.TO) To Hold Conference Call On Third Quarter Fiscal 2016 Financial Results On Wednesday, May 11th, At 4:30 P.M. EST 5/10/2016 7:24:25 AM
Transition Therapeutics (TTH.TO) Announces Dosing Of First Patient In Phase 2 Study Of Drug Candidate TT701 4/26/2016 6:03:00 AM
Eli Lilly (LLY) Abandons Development of Transition Therapeutics (TTH.TO)' Diabetes Candidate TT401 4/18/2016 6:11:22 AM
Transition Therapeutics (TTH.TO) Receives Notification From NASDAQ 3/18/2016 6:36:17 AM
Transition Therapeutics (TTH.TO) To Present At The 36th Annual Cowen Healthcare Conference 3/2/2016 7:42:32 AM
Transition Therapeutics (TTH.TO) Announces Second Quarter Fiscal 2016 Financial Results 2/10/2016 6:40:57 AM
Transition Therapeutics (TTH.TO) To Hold Conference Call On Second Quarter Fiscal 2016 Financial Results On Tuesday, February 9th, At 4:30 P.M. EST 2/8/2016 6:36:22 AM
Transition Therapeutics (TTH.TO) Announces Top Line Phase 2 Clinical Study Results Of Diabetes Drug Candidate TT401 2/1/2016 6:19:57 AM
Transition Therapeutics (TTH.TO) Announces Annual General Meeting Voting Results 1/6/2016 10:42:16 AM
12345678910...
//-->